Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany; and Forschergruppe Diabetes, Technical University Munich, at Klinikum rechts der Isar, Munich, and Forschergruppe Diabetes eV, Neuherberg, Germany.
DFG Center for Regenerative Therapies Dresden, Faculty of Medicine, TU Dresden, Dresden, Germany.
Am J Clin Nutr. 2021 Jul 1;114(1):134-142. doi: 10.1093/ajcn/nqab065.
Breastfeeding has beneficial effects on numerous health outcomes.
We investigated whether breastfeeding duration is associated with the development of early childhood autoimmunity, allergies, or obesity in a multinational prospective birth cohort.
Infants with genetic susceptibility for type 1 diabetes (n = 8676) were followed for the development of autoantibodies to islet autoantigens or transglutaminase, allergies, and for anthropometric measurements to a median age of 8.3 y (IQR: 2.8-10.2 y). Information on breastfeeding was collected at 3 mo of age and prospectively thereafter. A propensity score for longer breastfeeding was calculated from the variables that were likely to influence any or exclusive breastfeeding. The risks of developing autoimmunity or allergy were assessed using Cox proportional hazards models, and the risk of obesity at 5.5 y of age was assessed using logistic regression with adjustment by the propensity score.
Breastfeeding duration was not associated with a lower risk of either islet or transglutaminase autoimmunity (any breastfeeding >6 mo, adjusted HR: 1.07; 95% CI: 0.96, 1.19; exclusive breastfeeding >3 mo, adjusted HR: 1.03; 95% CI: 0.92, 1.15). Exclusive breastfeeding >3 mo was associated with a decreased risk of seasonal allergic rhinitis (adjusted HR: 0.70; 95% CI: 0.53, 0.92; P < 0.01). Any breastfeeding >6 mo and exclusive breastfeeding >3 mo were associated with decreased risk of obesity (adjusted OR: 0.62; 95% CI: 0.47, 0.81; P < 0.001; and adjusted OR: 0.68; 95% CI: 0.47, 0.95; P < 0.05, respectively).
Longer breastfeeding was not associated with a lower risk of childhood (islet or transglutaminase) autoimmunity in genetically at-risk children but was associated with decreased risk of seasonal allergic rhinitis and obesity at 5.5 y of age.
母乳喂养对许多健康结果都有有益影响。
我们研究了在一个多国前瞻性出生队列中,母乳喂养持续时间是否与婴幼儿自身免疫、过敏或肥胖的发展有关。
研究纳入了 8676 名具有 1 型糖尿病遗传易感性的婴儿,对其胰岛自身抗原或转谷氨酰胺酶自身抗体的发展、过敏以及人体测量学指标进行了随访,随访中位数年龄为 8.3 岁(IQR:2.8-10.2 岁)。在 3 月龄时收集母乳喂养信息,并在此后进行前瞻性收集。通过可能影响任何或纯母乳喂养的变量计算更长母乳喂养时间的倾向评分。使用 Cox 比例风险模型评估发生自身免疫或过敏的风险,使用调整倾向评分的逻辑回归评估 5.5 岁时肥胖的风险。
母乳喂养持续时间与胰岛或转谷氨酰胺酶自身免疫(任何母乳喂养>6 个月,调整 HR:1.07;95%CI:0.96,1.19;纯母乳喂养>3 个月,调整 HR:1.03;95%CI:0.92,1.15)的风险降低无关。纯母乳喂养>3 个月与季节性过敏性鼻炎的风险降低相关(调整 HR:0.70;95%CI:0.53,0.92;P<0.01)。任何母乳喂养>6 个月和纯母乳喂养>3 个月与肥胖风险降低相关(调整 OR:0.62;95%CI:0.47,0.81;P<0.001;和调整 OR:0.68;95%CI:0.47,0.95;P<0.05)。
在具有遗传易感性的儿童中,较长的母乳喂养与儿童(胰岛或转谷氨酰胺酶)自身免疫风险降低无关,但与 5.5 岁时季节性过敏性鼻炎和肥胖的风险降低有关。